# Your CMS GUIDE Partner for Specialized Dementia Support

[Learn more](https://my.synapticure.com/)

---

## From Bedside to Bench and Back to Patients

We believe the tools to develop cures for neurodegenerative diseases are on the horizon. Our care model removes barriers to advancing these cures—from diagnosis to clinical trials and research.

[Partner with Synapticure](mailto:partner@synapticure.com?subject=To%20Synapticure%20Research%20and%20Development%20Team)

### Scaled disease populations for robust research

### Specialist-led care models for precision insights

### Focus on fast access and comprehensive diagnostics

### Engaged patient populations actively participating in care

## How We Partner With Research and Life Science Companies

We remove barriers to advancing cures by scaling disease populations, leveraging specialist-led care models, and providing fast diagnostics and engaged patient populations.

###### Discovery

### Accelerate New Assets into Clinic

#### In-Vitro Modeling

- Patient-derived 3D brain models that faithfully recapitulate disease features, allowing our lab to screen promising therapeutics

- Proprietary cell models viable for new target discovery, target validation, and translational data generation

###### Clinical Development

### Get Disease-Altering Treatments to Patients Faster

#### Expanded Access Programs

- 50-state, rapidly enrolled Expanded Access programs

- Highly accessible patient engagement systems

- FDA-grade data collection and management

#### Clinical Trial Site / Hybrid Support

- Fully functional decentralized trial site operations

- Comprehensive support for recruitment, study assessments, in-home sample collection and more

###### Post-Approval / Commercial

### Understand What Works for Patients, When, and Why

#### Patient Access

- Access point for patients to engage with disease specialists and understand treatment options

#### Patient Journey Analytics

- Detailed insights and analytics to understand access, barriers and patient needs

- Track real-world care patterns across geographies and payers

- Identify friction points in diagnosis, referral, and treatment initiation

#### RWE: Prospective Studies

- Deeply phenotyped and diverse patient population

- Rapid enrollment through engaged clinicians across all 50 states

- Standardized clinical assessments and biosample collection at scale

#### RWE: Retrospective Studies

- High-fidelity retrospective population analysis; outcomes data for publication

- Longitudinal EMR data spanning early symptoms to long-term outcomes

- Rich data across demographics, comorbidities, and treatment patterns

## Partner with Synapticure to Transform Patient Outcomes

If you’re interested in discussing opportunities with our team or would like to connect at upcoming events, please contact us.

[Partner with Synapticure](mailto:partner@synapticure.com?subject=To%20Synapticure%20Research%20and%20Development%20Team)
